Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.290
+0.040 (16.05%)
At close: Nov 20, 2024, 4:00 PM
0.260
-0.030 (-10.24%)
Pre-market: Nov 21, 2024, 5:39 AM EST
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $5.37 million as of November 21, 2024. Its market cap has increased by 106.48% in one year.
Market Cap
5.37M
Enterprise Value
2.45M
1-Year Change
106.48%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $161.80M to $5.37M, a decrease of -96.68%. That is a compound annual growth rate of -33.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 4.60M | 43.75% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.35% |
| Dec 31, 2021 | 38.50M | -74.65% |
| Dec 31, 2020 | 151.90M | 413.18% |
| Dec 31, 2019 | 29.60M | 2.78% |
| Dec 31, 2018 | 28.80M | -68.32% |
| Dec 29, 2017 | 90.90M | 84.01% |
| Dec 30, 2016 | 49.40M | -69.47% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XORTX Therapeutics | 4.47M |
| Galmed Pharmaceuticals | 4.46M |
| Windtree Therapeutics | 4.33M |
| Pasithea Therapeutics | 4.28M |
| Portage Biotech | 3.99M |
| Aptorum Group | 3.98M |
| Chromocell Therapeutics | 3.85M |
| Biofrontera | 3.82M |